Financhill
Buy
55

UAMY Quote, Financials, Valuation and Earnings

Last price:
$2.78
Seasonality move :
27.95%
Day range:
$2.20 - $2.59
52-week range:
$0.21 - $2.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
18.56x
P/B ratio:
10.22x
Volume:
7.4M
Avg. volume:
2.8M
1-year change:
920%
Market cap:
$292.3M
Revenue:
$14.9M
EPS (TTM):
-$0.02

Earnings Data

Next earnings date for UAMY
May 15
2025
Most recent earnings per share
-$0.01
Missed by $0.01
(Mar 20/2025)
Consensus Estimate
--
(Mar 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

UAMY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $8.8M -- -- $0.01 --
05/15/2025 Q1 $7M -- -- -- --
03/20/2025 Q4 $4.5M $6.9M -$0.01 -- --
11/12/2024 Q3 -- $2.4M -$0.01 -- --
08/09/2024 Q2 -- $2.8M $0.00 -- --
05/15/2024 Q1 -- $2.8M -$0.00 -- --
12/31/2023 Q4 -- $2.2M -$0.03 -- --
11/13/2023 Q3 -- -- -$0.02 -- --
06/30/2023 Q2 -- -- -$0.00 -- --
03/31/2023 Q1 -- -- -$0.01 -- --
12/31/2022 Q4 -- -- -$0.01 -- --
11/14/2022 Q3 -- -- $0.00 -- --
08/16/2022 Q2 -- -- $0.00 -- --
05/16/2022 Q1 -- -- $0.01 -- --
12/31/2021 Q4 -- -- $0.00 -- --
11/15/2021 Q3 -- -- -$0.00 -- --
08/16/2021 Q2 -- -- $0.00 -- --
05/14/2021 Q1 -- -- -$0.00 -- --
12/31/2020 Q4 -- -- -$0.03 -- --
11/16/2020 Q3 -- -- -$0.01 -- --
08/19/2020 Q2 -- -- -$0.00 -- --
04/14/2020 Q1 -- -- -$0.00 -- --
12/31/2019 Q4 -- -- -$0.02 -- --
11/13/2019 Q3 -- -- -$0.02 -- --
08/13/2019 Q2 -- -- -$0.01 -- --
04/01/2019 Q1 -- -- -$0.01 -- --
12/31/2018 Q4 -- -- -- -- --
11/13/2018 Q3 -- -- $0.02 -- --
08/13/2018 Q2 -- -- -$0.00 -- --
05/11/2018 Q1 -- -- -$0.01 -- --
03/29/2018 Q4 -- -- -$0.01 -- --
09/30/2017 Q3 -- -- -$0.00 -- --
06/30/2017 Q2 -- -- -$0.00 -- --
03/31/2017 Q1 -- -- -$0.01 -- --
12/31/2016 Q4 -- -- -- -- --
11/14/2016 Q3 -- -- -$0.01 -- --
06/30/2016 Q2 -- -- -$0.00 -- --
03/31/2016 Q1 -- -- -$0.00 -- --
12/31/2015 Q4 -- -- -$0.01 -- --
09/30/2015 Q3 -- -- -$0.00 -- --
08/10/2015 Q2 -- -- -$0.00 -- --

United States Antimony Earnings Questions

  • How Much did United States Antimony Generate in Revenue Last Quarter?

    United States Antimony reported $6.9M worth of top line sales in its most recent quarter.

  • Did United States Antimony Beat Earnings Last Quarter?

    United States Antimony announced earnings per share of -$0.01 which represents a miss of analyst forecast a -- per share.

  • Is United States Antimony Profitable?

    United States Antimony reported $1.3M that represents $0.01 per share over the last quarter.

  • What is the Analyst Consensus for United States Antimony EPS Next Year?

    United States Antimony's earnings are forecast to grow from -$0.02 per share to $0.06 per share next year representing an increase of --.

  • When is United States Antimony's Earnings Date?

    United States Antimony's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do Tesla Delivery Numbers Mean for Tesla Stock?
What Do Tesla Delivery Numbers Mean for Tesla Stock?

Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…

Is Chewy a Growth Stock to Buy?
Is Chewy a Growth Stock to Buy?

It might be a surprise to learn that during the…

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Stock Ideas

Sell
45
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 31x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Sell
11
CRL alert for Apr 11

Charles River Laboratories International [CRL] is down 0.2% over the past day.

Buy
77
DPST alert for Apr 11

Direxion Daily Regional Banks Bull 3X Shares [DPST] is down 0.79% over the past day.

Sell
35
KMX alert for Apr 11

CarMax [KMX] is up 2.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock